NuVasive Inc (NuVasive) is a medical equipment company engaged in the development, manufacturing, and commercialization of various surgical products and services, catering to the requirements of surgeons and hospitals for the treatment of spine pathologies. The company markets its extensive portfolio of products in over 50 countries including the US, Puerto Rico, Brazil, Argentina, and Venezuela.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

NuVasive conducts its research and development(R&D) activities to advance its product platform and develop applications incorporating its technology into procedurally integrated surgical solutions. The company launched various new products and related enhancements which significantly expanded its MAS platform, including iGA. It also strategically acquired complementary assets and technology in spinal hardware. In FY2022, the company spent US$98.5 million on its R&D activities, as compared to US$92.6 million in FY2021, indicating an 8.2% of the total revenue. As of December 31, 2022, NuVasive had more than 1,500 issued and pending patents, including more than 750 US issued patents and over 400 trademarks worldwide. The company’s patents and patent applications cover biologics, including Osteocel Plus and Osteocel Pro, Formagraft and AttraX; MAS surgical access instrumentation and methodology, including its XLIF and X360 procedure and related aspects. It also includes neurophysiology enabled instrumentation and methodology; magnetic technology for non-invasive distraction of an implanted device, such as the MAGEC technology platform; implants and related instrumentation and targeting systems. It provides Artificial discs, including the Simplify Cervical Disc and related instrumentation. It provides digital imaging processing technology that generates high resolution images of the surgical field from low resolution scans, including the LessRay technology platform; and porous PEEK technology, which comprises of Cohere, Coalesce and Coalesce Straight interbody implants.